-
Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH, 2010: PHENIX: a comprehensive Python-based system for macromolecular structure solution[J]. Acta Crystallogr Sect D-Biol Crystallogr, 66, 213-221. doi: 10.1107/S0907444909052925
-
Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, Hilgenfeld R, 2002: Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain[J]. EMBO J, 21, 3213-3224. doi: 10.1093/emboj/cdf327
-
Arden KE, McErlean P, Nissen MD, Sloots TP, Mackay IM, 2006: Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections[J]. J Med Virol, 78, 1232-1240. doi: 10.1002/jmv.20689
-
Arruda E, Pitkaranta A, Witek TJ Jr, Doyle CA, Hayden FG, 1997: Frequency and natural history of rhinovirus infections in adults during autumn[J]. J Clin Microbiol, 35, 2864-2868. doi: 10.1128/JCM.35.11.2864-2868.1997
-
Barral PM, Sarkar D, Fisher PB, Racaniello VR, 2009: RIG-I is cleaved during picornavirus infection[J]. Virology, 391, 171-176. doi: 10.1016/j.virol.2009.06.045
-
Baxter A, Chambers M, Edfeldt F, Edman K, Freeman A, Johansson C, King S, Morley A, Petersen J, Rawlins P, Spadola L, Thong B, Van de Poel H, Williams N, 2011: Non-covalent inhibitors of rhinovirus 3C protease[J]. Bioorg Med Chem Lett, 21, 777-780. doi: 10.1016/j.bmcl.2010.11.110
-
Binford SL, Maldonado F, Brothers MA, Weady PT, Zalman LS, Meador JW, Matthews DA, Patick AK, 2005: Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor[J]. Antimicrob Agents Chemother, 49, 619-626. doi: 10.1128/AAC.49.2.619-626.2005
-
Bizzintino J, Lee WM, Laing IA, Vang F, Pappas T, Zhang G, Martin AC, Khoo SK, Cox DW, Geelhoed GC, McMinne PC, Goldblatt J, Gern JE, Le Soue PN, 2011: Association between human rhinovirus C and severity of acute asthma in children[J]. Eur Respir J, 37, 1037-1042. doi: 10.1183/09031936.00092410
-
Bochkov YA, Watters K, Ashraf S, Griggs TF, Devries MK, Jackson DJ, Palmenberg AC, Gern JE, 2015: Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication[J]. Proc Natl Acad Sci USA, 112, 5485-5490. doi: 10.1073/pnas.1421178112
-
Croft SN, Walker EJ, Ghildyal R, 2018: Human Rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation[J]. Sci Rep, 8, 1569-. doi: 10.1038/s41598-018-19839-4
-
DeLano WL, 2004: Use of PYMOL as a communications tool for molecular science[J]. Abstracts P Am Chem Soc, 228, U313-U314.
-
Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O, 2008: Phylogeny. fr: robust phylogenetic analysis for the non-specialist[J]. Nucleic Acids Res, 36, W465-469. doi: 10.1093/nar/gkn180
-
Dereeper A, Audic S, Claverie JM, Blanc G, 2010: BLAST-EXPLORER helps you building datasets for phylogenetic analysis[J]. BMC Evol Biol, 10, 8-. doi: 10.1186/1471-2148-10-8
-
Dragovich PS, Webber SE, Babine RE, Fuhrman SA, Patick AK, Matthews DA, Reich SH, Marakovits JT, Prins TJ, Zhou R, Tikhe J, Littlefield ES, Bleckman TM, Wallace MB, Little TL, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, DeLisle DM, Worland ST, 1998: Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.2. Peptide structure-activity studies[J]. J Med Chem, 41, 2819-2834. doi: 10.1021/jm9800696
-
Dragovich PS, Prins TJ, Zhou R, Fuhrman SA, Patick AK, Matthews DA, Ford CE, Meador JW, Ferre RA, Worland ST, 1999a: Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.3. Structure - Activity studies of ketomethylene-containing peptidomimetics[J]. J Med Chem, 42, 1203-1212.
-
Dragovich PS, Prins TJ, Zhou R, Webber SE, Marakovits JT, Fuhrman SA, Patick AK, Matthews DA, Lee CA, Ford CE, Burke BJ, Rejto PA, Hendrickson TF, Tuntland T, Brown EL, Meador JW, Ferre RA, Harr JEV, Kosa MB, Worland ST, 1999b: Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.4. Incorporation of P-1 lactam moieties as L-glutamine replacements[J]. J Med Chem, 42, 1213-1224.
-
Emsley P, Cowtan K, 2004: Coot: model-building tools for molecular graphics[J]. Acta Crystallogr Sect D-Biol Crystallogr, 60, 2126-2132. doi: 10.1107/S0907444904019158
-
Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marior CW, Kamarck ME, Mcclelland A, 1989: The major human rhinovirus receptor Is Icam-1[J]. Cell, 56, 839-847. doi: 10.1016/0092-8674(89)90688-0
-
Hao W, Bernard K, Patel N, Ulbrandt N, Feng H, Svabek C, Wilson S, Stracener C, Wang K, Suzich J, Blair W, Zhu Q, 2012: Infection and propagation of human rhinovirus C in human airway epithelial cells[J]. J Virol, 86, 13524-13532. doi: 10.1128/JVI.02094-12
-
Hofer F, Gruenberger M, Kowalski H, Machat H, Huettinger M, Kuechler E, Blaas D, 1994: Members of the low-density-lipoprotein receptor family mediate cell entry of a minor-group common cold virus[J]. Proc Natl Acad Sci USA, 91, 1839-1842. doi: 10.1073/pnas.91.5.1839
-
Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, Otoole S, Myint SH, Tyrrell DAJ, Holgate ST, 1995: Community study of role of viral-infections in exacerbations of asthma in 9-11 year-old children[J]. BMJ, 310, 1225-1229. doi: 10.1136/bmj.310.6989.1225
-
Lamson D, Renwick N, Kapoor V, Liu Z, Palacios G, Ju J, Dean A, George KS, Briese T, Lipkin WI, 2006: MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005[J]. J Infect Dis, 194, 1398-1402. doi: 10.1086/508551
-
Lee CC, Kuo CJ, Ko TP, Hsu MF, Tsui YC, Chang SC, Yang S, Chen SJ, Chen HC, Hsu MC, Shih SR, Liang PH, Wang AH, 2009: Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds[J]. J Biol Chem, 284, 7646-7655. doi: 10.1074/jbc.M807947200
-
Lotzerich M, Roulin PS, Boucke K, Witte R, Georgiev O, Greber UF, 2018: Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death[J]. Cell Death Dis, 9, 272-. doi: 10.1038/s41419-018-0306-6
-
Lu GW, Qi JX, Chen ZJ, Xu X, Gao F, Lin DZ, Qian WK, Liu H, Jiang HL, Yan JH, Gao GF, 2011: Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design[J]. J Virol, 85, 10319-10331. doi: 10.1128/JVI.00787-11
-
Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, Zhou R, Tikhe J, Ford CE, Meador JW, Ferre RA, Brown EL, Binford SL, Brothers MA, DeLisle DM, Worland ST, 1999: Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes[J]. Proc Natl Acad Sci USA, 96, 11000-11007. doi: 10.1073/pnas.96.20.11000
-
Mccoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ, 2007: Phaser crystallographic software[J]. J Appl Crystallogr, 40, 658-674. doi: 10.1107/S0021889807021206
-
Mello C, Aguayo E, Rodriguez M, Lee G, Jordan R, Cihlar T, Birkus G, 2014: Multiple classes of antiviral agents exhibit In Vitro activity against human rhinovirus type C[J]. Antimicrob Agents Chemother, 58, 1546-1555. doi: 10.1128/AAC.01746-13
-
Miller EK, Khuri-Bulos N, Williams JV, Shehabi AA, Faouri S, Al Jundi I, Chen QX, Heil L, Mohamed Y, Morin LL, Ali A, Halasa NB, 2009: Human rhinovirus C associated with wheezing in hospitalised children in the Middle East[J]. J Clin Virol, 46, 85-89. doi: 10.1016/j.jcv.2009.06.007
-
Mosimann SC, Cherney MM, Sia S, Plotch S, James MN, 1997: Refined X-ray crystallographic structure of the poliovirus 3C gene product[J]. J Mol Biol, 273, 1032-1047. doi: 10.1006/jmbi.1997.1306
-
Otwinowski Z, Minor W, 1997: Processing of X-ray diffraction data collected in oscillation mode[J]. Macromol Crystallogr Pt A, 276, 307-326. doi: 10.1016/S0076-6879(97)76066-X
-
Palmenberg AC, 1990: Proteolytic processing of picornaviral polyprotein[J]. Annu Rev Microbiol, 44, 603-623. doi: 10.1146/annurev.mi.44.100190.003131
-
Palmenberg AC, Rathe JA, Liggett SB, 2010: Analysis of the complete genome sequences of human rhinovirus[J]. J Allergy Clin Immunol, 125, 1190-1199. doi: 10.1016/j.jaci.2010.04.010
-
Patick AK, Binford SL, Brothers MA, Jackson RL, Ford CE, Diem MD, Maldonado F, Dragovich PS, Zhou R, Prins TJ, Fuhrman SA, Meador JW, Zalman LS, Matthews DA, Worland ST, 1999: In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease[J]. Antimicrob Agents Chemother, 43, 2444-2450. doi: 10.1128/AAC.43.10.2444
-
Porter AG, 1993: Picornavirus nonstructural proteins—emerging roles in virus-replication and inhibition of host-cell functions[J]. J Virol, 67, 6917-6921. doi: 10.1128/JVI.67.12.6917-6921.1993
-
Robert X, Gouet P, 2014: Deciphering key features in protein structures with the new ENDscript server[J]. Nucleic Acids Res, 42, W320-324. doi: 10.1093/nar/gku316
-
Tam JCH, Bidgood SR, McEwan WA, James LC, 2014: Intracellular sensing of complement C3 activates cell autonomous immunity[J]. Science, 345, 1134-.
-
Tsai MT, Cheng YH, Liu YN, Liao NC, Lu WW, Kung SH, 2009: Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer[J]. Antimicrob Agents Chemother, 53, 748-755. doi: 10.1128/AAC.00841-08
-
Wang QM, Chen SH, 2007: Human rhinovirus 3C protease as a potential target for the development of antiviral agents[J]. Curr Protein Pept Sci, 8, 19-27. doi: 10.2174/138920307779941523
-
Yang HT, Yang MJ, Ding Y, Liu YW, Lou ZY, Zhou Z, Sun L, Mo LJ, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao ZH, 2003: The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor[J]. Proc Natl Acad Sci USA, 100, 13190-13195. doi: 10.1073/pnas.1835675100